Pronunciation: ris-PER-i-doen
Mechanism of action: Risperidone LAI ballicule
Visual mnemonic: Risperidone LAI mascot
“Risp-Van” / “Wristband”
Spooky mascot → antipsychotic
Monthly injection
What it isDepot D2 and 5-HT2A antagonist risperidone; maintenance treatment of schizophrenia.
Why this oneMonthly intramuscular risperidone using in-situ-forming implant technology; no loading regimen and no oral supplementation.
What limits itProlactin elevation, parkinsonism, weight gain, and orthostasis limit use; CYP2D6 inhibitors and CYP3A4 inducers alter exposure.
Molecular structure: Risperidone LAI
⚠ BOXED WARNING
- Increased mortality in elderly patients with dementia-related psychosis
Classes and tags
Clinical profile
Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability2 / 4
Sedation liability2 / 4
QT / Torsades1 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4
Legacy pregnancy categoryC
Defining liabilityMetabolic effects, extrapyramidal symptoms/tardive dyskinesia and agent-specific QT or orthostatic risk.
Active metabolites
Open Risperidone LAI in the interactive console ↗